@article {EllisS18, author = {Stephen G. Ellis and Haris Riaz}, title = {Bioresorbable stents: The future of interventional cardiology?}, volume = {83}, number = {11 suppl 2}, pages = {S18--S23}, year = {2016}, doi = {10.3949/ccjm.83.s2.03}, publisher = {Cleveland Clinic Journal of Medicine}, abstract = {The introduction of stents has drastically reduced target-lesion restenosis rates associated with percutaneous coronary angioplasty. Bare-metal stents were the first introduced, followed by drug-eluting stents, both of which had significant impacts on the complication rates. Stents, however, have resulted in the emergence of stent thrombosis and stent restenosis, which can cause life-threatening cardiac complications. Three new technological approaches are being investigated to overcome these complications: stents coated with bioresorbable polymers, stents without polymers, and completely bioresorbable stents. Initial results are encouraging, but more data are needed to ascertain their implications for clinical practice.}, issn = {0891-1150}, URL = {https://www.ccjm.org/content/83/11_suppl_2/S18}, eprint = {https://www.ccjm.org/content/83/11_suppl_2/S18.full.pdf}, journal = {Cleveland Clinic Journal of Medicine} }